+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Vaccine Adjuvants Market Analysis 2019

  • ID: 4857833
  • Report
  • November 2019
  • Region: Global
  • 134 pages
  • Syngene Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Agenus Inc
  • Avanti Polar Lipids Inc
  • CSL Limited
  • Invivogen
  • MVP Laboratories Inc
  • Novavax Inc
  • MORE
The Global Vaccine Adjuvants market is expected to reach $1442.60 million by 2026 growing at a CAGR of 12.3% during 2018 to 2026. Vaccine adjuvant is an immunological agent that is added to the vaccine to provide long-lasting protection against antigen and enhance the immune response. Vaccine adjuvant can modify the effect of other agents.

Some of the factors such as increasing government recommendations for immunizations and technological advancements in aluminum hydroxide based adjuvants are fuelling the market growth. However, stringent regulatory environment and time-consuming approvals is restraining the market growth.

Based on Application, Research Application segment has witnessed significant growth due to the factors such as ongoing research projects on new adjuvants, increasing activities by government bodies and organizations, increasing usage of vaccine adjuvants commercially, and high occurrences of zoonotic diseases.

The key vendors mentioned are Agenus Inc, Avanti Polar Lipids Inc, Brenntag Biosector A/S (A Subsidiary of Brenntag AG), CSL Limited, Invivogen, MVP Laboratories Inc, Novavax Inc, OZ Biosciences, Seppic (A Subsidiary of Air Liquide Group) and SPI Pharma Inc (A Subsidiary of Associated British Foods PLC).

Disease Types Covered:
  • Cancer
  • Infectious Diseases
Route of Administrations Covered:
  • Intradermal Route
  • Intramuscular Route
  • Intranasal Route
  • Oral Route
  • Subcutaneous Route
Applications Covered:
  • Commercial Application
  • Research Application
Products Covered:
  • Adjuvant Emulsions
  • Combination Adjuvants
  • Particulate Adjuvants
  • Pathogen Components
Types Covered:
  • Adjuvant Emulsions
  • Bacteria-derived Adjuvants
  • Carbohydrate Adjuvants
  • Liposome Adjuvants
  • Mineral Salt-based Adjuvant
  • Organic Adjuvants
  • Tensoactive Adjuvants
  • Virus-like Particles (VLP)
Mechanism of Actions Covered:
  • Active Immunostimulants
  • Carriers
  • Vehicle Adjuvants
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analyzed during the forecast period

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agenus Inc
  • Avanti Polar Lipids Inc
  • CSL Limited
  • Invivogen
  • MVP Laboratories Inc
  • Novavax Inc
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Vaccine Adjuvants Market, By Disease Type
5.1 Introduction
5.2 Cancer
5.3 Infectious Diseases

6 Global Vaccine Adjuvants Market, By Route of Administration
6.1 Introduction
6.2 Intradermal Route
6.3 Intramuscular Route
6.4 Intranasal Route
6.5 Oral Route
6.6 Subcutaneous Route

7 Global Vaccine Adjuvants Market, By Application
7.1 Introduction
7.2 Commercial Application
7.3 Research Application

8 Global Vaccine Adjuvants Market, By Product
8.1 Introduction
8.2 Adjuvant Emulsions
8.3 Combination Adjuvants
8.4 Particulate Adjuvants
8.5 Pathogen Components

9 Global Vaccine Adjuvants Market, By Type
9.1 Introduction
9.2 Adjuvant Emulsions
9.3 Bacteria-derived Adjuvants
9.4 Carbohydrate Adjuvants
9.5 Liposome Adjuvants
9.6 Mineral Salt-based Adjuvant
9.7 Organic Adjuvants
9.8 Tensoactive Adjuvants
9.9 Virus-like Particles (VLP)

10 Global Vaccine Adjuvants Market, By Mechanism of Action
10.1 Introduction
10.2 Active Immunostimulants
10.3 Carriers
10.4 Vehicle Adjuvants

11 Global Vaccine Adjuvants Market, By Geography
11.1 North America
11.2 Europe
11.3 Asia Pacific
11.4 South America
11.5 Middle East & Africa

12 Strategic Benchmarking

13 Vendors Landscape
13.1 Agenus Inc
13.2 Avanti Polar Lipids Inc
13.3 Brenntag Biosector A/S (A Subsidiary of Brenntag AG)
13.4 CSL Limited
13.5 Invivogen
13.6 MVP Laboratories Inc
13.7 Novavax Inc
13.8 OZ Biosciences
13.9 Seppic (A Subsidiary of Air Liquide Group)
13.10 SPI Pharma Inc (A Subsidiary of Associated British Foods PLC)

List of Data Tables
Table 1 Global Vaccine Adjuvants Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Vaccine Adjuvants Market Outlook, By Disease Type (2016-2026) ($MN)
Table 3 Global Vaccine Adjuvants Market Outlook, By Cancer (2016-2026) ($MN)
Table 4 Global Vaccine Adjuvants Market Outlook, By Infectious Diseases (2016-2026) ($MN)
Table 5 Global Vaccine Adjuvants Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 6 Global Vaccine Adjuvants Market Outlook, By Intradermal Route (2016-2026) ($MN)
Table 7 Global Vaccine Adjuvants Market Outlook, By Intramuscular Route (2016-2026) ($MN)
Table 8 Global Vaccine Adjuvants Market Outlook, By Intranasal Route (2016-2026) ($MN)
Table 9 Global Vaccine Adjuvants Market Outlook, By Oral Route (2016-2026) ($MN)
Table 10 Global Vaccine Adjuvants Market Outlook, By Subcutaneous Route (2016-2026) ($MN)
Table 11 Global Vaccine Adjuvants Market Outlook, By Application (2016-2026) ($MN)
Table 12 Global Vaccine Adjuvants Market Outlook, By Commercial Application (2016-2026) ($MN)
Table 13 Global Vaccine Adjuvants Market Outlook, By Research Application (2016-2026) ($MN)
Table 14 Global Vaccine Adjuvants Market Outlook, By Product (2016-2026) ($MN)
Table 15 Global Vaccine Adjuvants Market Outlook, By Adjuvant Emulsions (2016-2026) ($MN)
Table 16 Global Vaccine Adjuvants Market Outlook, By Combination Adjuvants (2016-2026) ($MN)
Table 17 Global Vaccine Adjuvants Market Outlook, By Particulate Adjuvants (2016-2026) ($MN)
Table 18 Global Vaccine Adjuvants Market Outlook, By Pathogen Components (2016-2026) ($MN)
Table 19 Global Vaccine Adjuvants Market Outlook, By Type (2016-2026) ($MN)
Table 20 Global Vaccine Adjuvants Market Outlook, By Adjuvant Emulsions (2016-2026) ($MN)
Table 21 Global Vaccine Adjuvants Market Outlook, By Bacteria-derived Adjuvants (2016-2026) ($MN)
Table 22 Global Vaccine Adjuvants Market Outlook, By Carbohydrate Adjuvants (2016-2026) ($MN)
Table 23 Global Vaccine Adjuvants Market Outlook, By Liposome Adjuvants (2016-2026) ($MN)
Table 24 Global Vaccine Adjuvants Market Outlook, By Mineral Salt-based Adjuvant (2016-2026) ($MN)
Table 25 Global Vaccine Adjuvants Market Outlook, By Organic Adjuvants (2016-2026) ($MN)
Table 26 Global Vaccine Adjuvants Market Outlook, By Tensoactive Adjuvants (2016-2026) ($MN)
Table 27 Global Vaccine Adjuvants Market Outlook, By Virus-like Particles (VLP) (2016-2026) ($MN)
Table 28 Global Vaccine Adjuvants Market Outlook, By Mechanism of Action (2016-2026) ($MN)
Table 29 Global Vaccine Adjuvants Market Outlook, By Active Immunostimulants (2016-2026) ($MN)
Table 30 Global Vaccine Adjuvants Market Outlook, By Carriers (2016-2026) ($MN)
Table 31 Global Vaccine Adjuvants Market Outlook, By Vehicle Adjuvants (2016-2026) ($MN)
Table 32 North America Vaccine Adjuvants Market Outlook, By Product (2016-2026) ($MN)
Table 33 North America Vaccine Adjuvants Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 34 North America Vaccine Adjuvants Market Outlook, By Disease Type (2016-2026) ($MN)
Table 35 North America Vaccine Adjuvants Market Outlook, By Application (2016-2026) ($MN)
Table 36 North America Vaccine Adjuvants Market Outlook, By Type (2016-2026) ($MN)
Table 37 North America Vaccine Adjuvants Market Outlook, By Mechanism of Action (2016-2026) ($MN)
Table 38 Europe Vaccine Adjuvants Market Outlook, By Product (2016-2026) ($MN)
Table 39 Europe Vaccine Adjuvants Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 40 Europe Vaccine Adjuvants Market Outlook, By Disease Type (2016-2026) ($MN)
Table 41 Europe Vaccine Adjuvants Market Outlook, By Application (2016-2026) ($MN)
Table 42 Europe Vaccine Adjuvants Market Outlook, By Type (2016-2026) ($MN)
Table 43 Europe Vaccine Adjuvants Market Outlook, By Mechanism of Action (2016-2026) ($MN)
Table 44 Asia Pacific Vaccine Adjuvants Market Outlook, By Product (2016-2026) ($MN)
Table 45 Asia Pacific Vaccine Adjuvants Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 46 Asia Pacific Vaccine Adjuvants Market Outlook, By Disease Type (2016-2026) ($MN)
Table 47 Asia Pacific Vaccine Adjuvants Market Outlook, By Application (2016-2026) ($MN)
Table 48 Asia Pacific Vaccine Adjuvants Market Outlook, By Type (2016-2026) ($MN)
Table 49 Asia Pacific Vaccine Adjuvants Market Outlook, By Mechanism of Action (2016-2026) ($MN)
Table 50 South America Vaccine Adjuvants Market Outlook, By Product (2016-2026) ($MN)
Table 51 South America Vaccine Adjuvants Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 52 South America Vaccine Adjuvants Market Outlook, By Disease Type (2016-2026) ($MN)
Table 53 South America Vaccine Adjuvants Market Outlook, By Application (2016-2026) ($MN)
Table 54 South America Vaccine Adjuvants Market Outlook, By Type (2016-2026) ($MN)
Table 55 South America Vaccine Adjuvants Market Outlook, By Mechanism of Action (2016-2026) ($MN)
Table 56 Middle East & Africa Vaccine Adjuvants Market Outlook, By Product (2016-2026) ($MN)
Table 57 Middle East & Africa Vaccine Adjuvants Market Outlook, By Route of Administration (2016-2026) ($MN)
Table 58 Middle East & Africa Vaccine Adjuvants Market Outlook, By Disease Type (2016-2026) ($MN)
Table 59 Middle East & Africa Vaccine Adjuvants Market Outlook, By Application (2016-2026) ($MN)
Table 60 Middle East & Africa Vaccine Adjuvants Market Outlook, By Type (2016-2026) ($MN)
Table 61 Middle East & Africa Vaccine Adjuvants Market Outlook, By Mechanism of Action (2016-2026) ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Agenus Inc
  • Avanti Polar Lipids Inc
  • Brenntag Biosector A/S (A Subsidiary of Brenntag AG)
  • CSL Limited
  • Invivogen
  • MVP Laboratories Inc
  • Novavax Inc
  • OZ Biosciences
  • Seppic (A Subsidiary of Air Liquide Group)
  • SPI Pharma Inc (A Subsidiary of Associated British Foods PLC)
Note: Product cover images may vary from those shown
Adroll
adroll